Stock Analysis
Data Source: SEC EDGAR 13F
Updated Hourly

Neurocrine Biosciences Inc (NBIX)

687 + Investors. Track Smart Money conviction in NBIX. See who's accumulating, reducing, or initiating positions.

Fetching live quote...
Current Price
-- USD
Analyst Target
-- (0 analysts)
Upside
0.00%
Net Flow Q/Q
↓ -29
Streak
1Q ▼
Buyers last Q
53%

Smart Money Signals — NBIX

Based on 692 hedge funds · latest filing: 2026 Q1 · updated quarterly

📉

Selling streak — 1 quarter in a row

last 6Q
For 1 consecutive quarter, more hedge funds reduced or closed their NBIX positions than added to them. Sustained institutional selling is a meaningful warning sign — these are professionals with deep research teams collectively deciding to exit.
🏔️

At the ownership peak (96% of max)

96% of all-time peak
692 hedge funds hold NBIX right now — the highest count in 3.0 years. When ownership is this concentrated, any bad news can trigger a chain reaction: one big fund sells, others follow. This is a classic 'crowded trade' — high popularity doesn't equal safety.
🚀

Fast accumulation — +21% more funds vs a year ago

fund count last 6Q
+120 new funds entered over the past year (+21% YoY). That's a rapid rush of institutional money. Fast accumulation often signals a major thesis — but it also means the stock could fall quickly if that thesis breaks.
🟡

Slight buying edge — 53% buying

382 buying340 selling
Last quarter: 382 funds bought or added vs 340 that reduced or exited. It's nearly a 50/50 split — some institutions are convinced, others are taking profits. This mixed picture is normal near price highs.
⚠️

Fewer new buyers each quarter (-53 vs last Q)

new funds entering per quarter
Funds opening this position for the first time: 80 → 120 → 141 → 88. Each quarter fewer new institutions are entering. This usually means most funds that wanted in are already in — the stock is well-known but the pool of potential new buyers is shrinking.
🔒

59% of holders stayed for 2+ years

59% conviction (2yr+) 18% medium 23% new
406 out of 692 hedge funds have held NBIX for over 2 years without selling. Long-term investors are generally harder to shake out during market stress, creating a stable ownership base that limits the risk of sudden capitulation.
📈

Growing discovery — still being found

76 → 80 → 120 → 141 → 88 new funds/Q
New funds entering each quarter: 80 → 120 → 141 → 88. A growing number of institutions are discovering NBIX each quarter. The narrative is still spreading — leaving room for ongoing capital accumulation.
🏛️

Veteran-anchored — 61% veterans vs 27% newcomers

61% veterans 12% 1-2yr 27% new
Entry-cohort mix of 708 holders: 432 (61%) are 2+ year veterans, 84 entered 1–2 years ago, and 192 (27%) joined within the past year. A veteran-weighted cap table skews toward institutional memory over fresh momentum.
🏆

Elite ownership — 40% AUM from top-100 funds

40% from top-100 AUM funds
66 of 691 holders are among the 100 largest funds by AUM, controlling 40% of total institutional value in NBIX. When the biggest players dominate the cap table, it signifies deep institutional support — since mega-funds deploy the most rigorous due diligence and capital.
3.8
out of 10
Low Exit Risk
Exit risk score 3.8/10 — low institutional crowding. Ownership is below peak levels, holder base is relatively sticky, and buying momentum is positive.

Methodology note: these Smart Money cards use consecutive 13F disclosure snapshots, not trade-by-trade execution data. "Buying", "selling", "new holders", and "trimmed" refer to quarter-over-quarter changes in reported holders, aggregate shares, or disclosed position values between filings. They are useful for ownership regime analysis and crowding, but they do not imply exact trade timing on the filing date.

Institutional Sentiment Summary — NBIX

In 2026 Q1, 382 hedge funds were net buyers of NBIX (88 opened a new position, 294 added to an existing one), while 340 reduced or exited (223 trimmed, 117 sold completely) — a 53% buyer ratio, indicating a slight buying edge. 40% of total institutional value in NBIX is held by top-100 AUM funds, reflecting elite-tier ownership quality. Net fund flow last quarter: -29 funds (more exits than new entries). Total institutional holders: 692.

Hedge Fund Ownership: NBIX

How many hedge funds hold NBIX — quarterly history vs. share price
Quarterly hedge fund ownership of NBIX vs. share price

Market Analysis: NBIX

Analyst Price Targets

Avg. Price Target
--

Analyst Recommendations

Stock Performance

Real-time

Company Profile: NBIX

-- --

Institutional ownership data sourced from SEC EDGAR Form 13F-HR filings.

Is It Too Late to Buy Neurocrine Biosciences Inc (NBIX) Based on Hedge Fund 13F Filings?

Signal Freshness measures how much NBIX has moved relative to its sector benchmark (XLV) since the 2026 Q1 13F filing. A stock that has barely outrun its sector is still a relatively fresh entry point — the fund's thesis has not yet been priced in by the broader market.

Since Quarter End March 31, 2026 · 78d ago
NBIX
+21.3%
XLV
+3.0%

NBIX outperformed XLV by +18.3% since March 31, 2026.

Since 13F Filing Date May 15, 2026 · 33d ago
NBIX
+0.9%
XLV
+4.1%

Since the filing became public, NBIX outperformed XLV by -3.2% .

Interpretation: The stock is tracking its sector benchmark closely. The signal remains fresh and the entry point is still near the fund's implied reference. Learn more →

Smart Money Signal ?
Broad Consensus, Selective Conviction

Many quality funds hold this stock, but top-tier positions remain relatively small.

39 top-rated funds 4 high-conviction
Consensus
7.0
/ 10
breadth
×
Elite
3.1
/ 10
conviction
Hedge Fund Positioning: NBIX
687 + Investors

Track Smart Money conviction in NBIX. See who's accumulating, reducing, or initiating positions.

Metric All 13F Filers (2026 Q1) Prior (2025 Q4) Change
Funds Holding 687 721 -4.72%
13F Shares 95M 100M -4.7%
Total Value $12.26B $13.85B -11.49%
New Positions 86 141 -55
Increased Positions 288 272 +16
Closed Positions 120 54 +66
Reduced Positions 218 219 -1
Total Calls 9 11 -18.18%
Total Puts 8 8 -
PUT/CALL Ratio 0.89 0.73 Neutral

Statistics: NBIX

View More

Valuation Measures Data as of: --

Market Cap --
Enterprise Value --
Trailing P/E --
Forward P/E --
PEG Ratio (5yr expected) --
Price/Sales (ttm) --
Price/Book (mrq) --
Enterprise Value/Revenue --
Enterprise Value/EBITDA --
Beta (5Y Monthly) --
Short Ratio (Days to Cover) --
Short % of Float --

Financial Highlights

Profitability
Profit Margin --
Return on Assets (ttm) --
Return on Equity (ttm) --
Income Statement & Cash Flow
Revenue (ttm) --
Net Income Avi to Common (ttm) --
Diluted EPS (ttm) --
Total Cash (mrq) --
Total Debt/Equity (mrq) --
Levered Free Cash Flow (ttm) --

Institutional Holders (2026 Q1)

687 + investors

Explore institutional interest and hedge fund ownership dynamics. Analyze portfolio weights, new positions, and conviction trends in NBIX. Verified SEC 13F-HR filings.

QUARTER:
Top 25 NBIX holders by conviction (% of portfolio weight) — 2026 Q1 · Source: SEC Form 13F
# Investor % of Portfolio Shares Mkt Value
1 Sarissa Capital Management LP 9.74% 116,533 $15.4M
2 PKO BP BANKOWY Universal Pension Society JSC 8.55% 138,802 $18.3M
3 Vestal Point Capital, LP 4.60% 1,250,000 $164.7M
4 Defilade Capital Management, L.P. 3.88% 209,932 $27.7M
5 Braidwell LP 2.87% 652,121 $85.9M
6 PFM Health Sciences, LP 2.59% 215,678 $28.4M
7 Atle Fund Management AB 2.54% 89,685 $7.9M
8 Arrowpoint Investment Partners (Singapore) Pte. Ltd. 2.52% 21,556 $2.8M
9 DAFNA Capital Management LLC 2.12% 70,615 $9.3M
10 Birchview Capital, LP 2.04% 27,190 $3.6M
11 Armistice Capital, LLC 1.70% 724,000 $95.4M
12 Rhenman & Partners Asset Management AB 1.64% 100,841 $13.3M
13 Vienna Powszechne Towarzystwo Emerytalne S.A. Vienna Insurance Group 1.53% 30,400 $4.0M
14 Rtw Investments, LP 1.39% 1,062,072 $139.9M
15 Renaissance Group LLC 1.36% 246,377 $32.5M
16 Parkman Healthcare Partners LLC 1.35% 99,069 $13.1M
17 AlphaCentric Advisors LLC 1.26% 9,607 $1.3M
18 Gray Foundation 1.26% 37,800 $5.0M
19 Rock Springs Capital Management LP 1.17% 150,450 $19.8M
20 Paragon Capital Management Inc 1.11% 9,954 $1.3M
21 Ground Swell Capital, LLC 0.98% 3,767 $496K
22 Illumine Investment Management, LLC 0.98% 9,632 $1.3M
23 Deerfield Management Company, L.P. 0.95% 610,000 $80.4M
24 Integral Health Asset Management, LLC 0.95% 150,000 $19.8M
25 Red Spruce Capital, LLC 0.93% 17,209 $2.3M
Investor Ownership
History
% of Portfolio Prev % Rank Conviction Avg Buy Price 13F Score™ 3Y / 7Y Sell Timing Shares Mkt Value Change Change % Source Quarter Filed

Frequently Asked Questions — Neurocrine Biosciences Inc (NBIX)

What does the Smart Money Trend signal show for NBIX?

Selling streak — 1 quarter in a row: For 1 consecutive quarter, more hedge funds reduced or closed their NBIX positions than added to them. Sustained institutional selling is a meaningful warning sign — these are professionals with deep research teams collectively deciding to exit.

What is the institutional breadth score for NBIX?

Slight buying edge — 53% buying: Last quarter: 382 funds bought or added vs 340 that reduced or exited. It's nearly a 50/50 split — some institutions are convinced, others are taking profits. This mixed picture is normal near price highs.

What is the fund quality score for NBIX holders?

Elite ownership — 40% AUM from top-100 funds: 66 of 691 holders are among the 100 largest funds by AUM, controlling 40% of total institutional value in NBIX. When the biggest players dominate the cap table, it signifies deep institutional support — since mega-funds deploy the most rigorous due diligence and capital.

How long have hedge funds held NBIX?

59% of holders stayed for 2+ years: 406 out of 692 hedge funds have held NBIX for over 2 years without selling. Long-term investors are generally harder to shake out during market stress, creating a stable ownership base that limits the risk of sudden capitulation.

Is it too late to buy Neurocrine Biosciences Inc (NBIX) following the 2026 Q1 hedge fund 13F filings?

As of today, NBIX has moved +0.9% since the 2026 Q1 13F filing date (May 15, 2026), compared to +4.1% for the XLV sector ETF — an outperformance of -3.2%. Since the quarter end (March 31, 2026), NBIX has gained +21.3% vs +3.0% for XLV. The stock is tracking its sector benchmark closely. The signal remains fresh and the entry point is still near the fund's implied reference.

Where does this institutional ownership data come from?

All holdings data is sourced from SEC Form 13F filings, which institutional investment managers with over $100 million in assets are required to submit quarterly. Data is parsed directly from SEC EDGAR.

Disclaimer: The information on this page is for informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Institutional holdings data is sourced from SEC Form 13F filings and reflects positions as of the filing date. Past performance of any fund or portfolio is not indicative of future results. 13Foresight is not a registered investment adviser. Always conduct your own due diligence before making investment decisions.

Full history →